Mission Wealth Management LP Grows Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Mission Wealth Management LP grew its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 20.1% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 3,022 shares of the financial services provider’s stock after acquiring an additional 506 shares during the quarter. Mission Wealth Management LP’s holdings in iShares Biotechnology ETF were worth $410,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently modified their holdings of the company. Glass Jacobson Investment Advisors llc raised its stake in shares of iShares Biotechnology ETF by 150.6% in the third quarter. Glass Jacobson Investment Advisors llc now owns 203 shares of the financial services provider’s stock worth $25,000 after buying an additional 122 shares during the period. Values First Advisors Inc. purchased a new stake in shares of iShares Biotechnology ETF in the fourth quarter worth $43,000. Tennessee Valley Asset Management Partners bought a new stake in shares of iShares Biotechnology ETF during the 4th quarter valued at $44,000. Column Capital Advisors LLC bought a new stake in shares of iShares Biotechnology ETF during the 3rd quarter valued at $49,000. Finally, Massmutual Trust Co. FSB ADV lifted its stake in shares of iShares Biotechnology ETF by 164.2% during the 4th quarter. Massmutual Trust Co. FSB ADV now owns 362 shares of the financial services provider’s stock valued at $49,000 after buying an additional 225 shares in the last quarter. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Trading Up 1.8 %

Shares of IBB stock opened at $132.96 on Friday. The stock has a fifty day simple moving average of $133.61 and a two-hundred day simple moving average of $129.99. iShares Biotechnology ETF has a 52-week low of $111.83 and a 52-week high of $141.16.

iShares Biotechnology ETF Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 27th. Stockholders of record on Friday, March 22nd were given a dividend of $0.126 per share. This represents a $0.50 annualized dividend and a dividend yield of 0.38%. The ex-dividend date of this dividend was Thursday, March 21st.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.